Physician profile
Robert M Coale
NPI 1942413828
$3,913.90
in general payments reported to CMS, 2019-2025
15 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $1,619 · 2021: $321 · 2022: $116 · 2023: $150 · 2024: $1,401 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,384 · Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,384.38 |
| Food and Beverage | $326.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $1,493.28 | 2020-2023 | |
| Shoulder Innovations, INC. | $1,491.10 | 2024-2025 | Inset System |
| Horizon Therapeutics Plc | $485.76 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $115.08 | 2023 | Rosa |
| Depuy Synthes Sales INC. | $56.39 | 2020-2025 | Monovisc, Orthovisc |
| Stryker Corporation | $56.35 | 2019-2022 | |
| Bioventus LLC | $46.27 | 2021-2022 | |
| Medline Industries Lp | $38.73 | 2019 | |
| Medical Device Business Services, INC. | $23.22 | 2019 | |
| Smith+Nephew, INC. | $22.14 | 2022 | |
| Next Science LLC | $21.50 | 2025 | Xperience, Blastx |
| Organogenesis INC. | $19.58 | 2020 | |
| Hemosonics LLC | $16.40 | 2024 | Quantra Qplus System, Qunatra Qplus System |
| Ethicon US, LLC | $15.77 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Coale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.